Clinical trial
Evaluation of the Effect of Symptomatic Upper Respiratory Infections on Pharmacological Characteristics of Technosphere®/Insulin in Subjects With Diabetes Mellitus After a Meal Challenge
NCT00642681 is registered in ClinicalTrials.gov with Mannkind Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effect of Symptomatic Upper Respiratory Infections on Pharmacological Characteristics of Technosphere®/Insulin in Subjects With Diabetes Mellitus After a Meal Challenge
- Lead sponsor
- Mannkind Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- August 31, 2008
- Enrollment
- 20 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, upper respiratory infection